Untargeted UHPLC‐Q‐Exactive Orbitrap MS and Targeted UHPLC‐QqQ‐MS/MS for Exploring the Effective Components of “Wen Tong Plaster” Cataplasm in Treating Rats With Primary Dysmenorrhea

{"\\"Wen":[0,39,119,153,181,256,275],"Tong":[1,40,120,154,182,257,276],"Plaster\\"":[2,41,121,155,183,258,277],"is":[3],"renowned":[4],"for":[5,255,286],"its":[6,19],"therapeutic":[7,253],"effects":[8],"of":[9,38,65,78,97,99,110,152,209,274,292],"warming":[10],"meridians,":[11],"dispelling":[12],"cold,":[13],"and":[14,22,43,49,61,74,136,140,162,168,190,200,216,269,283,294],"promoting":[15],"blood":[16],"circulation.":[17],"However,":[18],"chemical":[20,36,113],"composition":[21],"active":[23,80],"pharmacological":[24],"substances":[25],"have":[26],"yet":[27],"to":[28,93,170,242],"be":[29],"fully":[30],"elucidated.":[31],"In":[32,133,260],"this":[33],"study,":[34],"the":[35,44,62,66,75,95,118,196,206,212,235,243,262,265,290],"components":[37,46,69,82,114,126,145,229],"cataplasm":[42,122,156,184],"transdermal":[45,68,81,102,131,144],"in":[47,50,70,83,117,129,142,195,211,270],"vivo":[48,84,143],"vitro":[51,71,130,271],"were":[52,72,115,146,157,192,219],"comprehensively":[53],"analyzed":[54],"by":[55,159,203],"mass":[56],"spectrometry":[57],"targeted":[58],"quantification":[59],"method,":[60],"release":[63,150,178,272],"kinetics":[64,151,273],"main":[67],"evaluated,":[73],"concentration-time":[76,207],"variation":[77],"key":[79,100],"was":[85,91],"studied,":[86],"finally":[87],"molecular":[88,222],"docking":[89,223],"technology":[90],"used":[92],"predict":[94],"mechanism":[96,291],"action":[98,293],"bioactive":[101],"components.":[103],"Using":[104],"UHPLC-Q-Exactive":[105],"Orbitrap":[106],"MS,":[107],"a":[108,171,251,280],"total":[109],"129":[111],"plant":[112],"found":[116],"extract,":[123],"with":[124,234],"41":[125],"detected":[127],"as":[128,250],"compounds.":[132],"subcutaneous":[134,197,213],"tissue":[135,202,218],"uterine":[137],"tissue,":[138,198,214],"53":[139],"36":[141],"characterized,":[147],"respectively.":[148],"The":[149,221],"evaluated":[158],"tetrahydropalmatine,":[160,186],"corydaline,":[161,187],"dihydrotanshinone":[163,188],"I,":[164,189],"three":[165],"marker":[166],"components,":[167],"fitted":[169],"first-order":[172],"kinetic":[173],"model":[174],"based":[175],"on":[176,289],"integrated":[177],"kinetics.":[179],"After":[180],"administration,":[185],"α-cyperone":[191],"accurately":[193],"quantified":[194],"plasma,":[199,215],"uterus":[201,217],"UHPLC-QqQ-MS/MS,":[204],"while":[205],"changes":[208],"them":[210],"investigated.":[220],"results":[224],"indicated":[225],"that":[226],"all":[227],"four":[228],"exhibited":[230],"favorable":[231],"binding":[232,240],"affinity":[233],"targets,":[236],"particularly":[237],"demonstrating":[238],"strong":[239],"capacity":[241],"cytochrome":[244],"P450":[245],"1A1":[246],"target,":[247],"suggesting":[248],"it":[249],"potential":[252],"target":[254],"cataplasm.":[259],"summary,":[261],"study":[263],"revealed":[264],"pharmacodynamic":[266],"material":[267],"basis":[268],"cataplasm,":[278],"providing":[279],"theoretical":[281],"foundation":[282],"data":[284],"support":[285],"further":[287],"research":[288],"clinical":[295],"application.":[296]}